FDA approves ultrasound TTTS treatment within 24 months
Resolves: FDA issues a press release or regulatory notice approving the ultrasound-based TTTS treatment device for commercial sale in the US.
user-generated· regulatory
FDA approves ultrasound TTTS treatment within 24 months
Market overview
The FDA will grant 510(k) clearance for the non-invasive ultrasound procedure developed by Imperial College and Queen Charlotte's Hospital to treat TTTS, based on the success of follow-up trials and safety data. This approval will enable widespread clinical adoption in US hospitals.
regulatory prediction market
- Implied probability (Yes)
- 70%
- Closes
- 2028-06-30
About this prediction
Resolution criteria
FDA issues a press release or regulatory notice approving the ultrasound-based TTTS treatment device for commercial sale in the US.
Source: user-generated
More regulatory markets
- Canada passes expanded cyber powers law by Q1 2027 — 65% Yes
- Tennessee redistricting plan passes legislature by May 31, 2026 — 75% Yes
- DOJ releases tapes to Congress by October 2026 — 55% Yes
- Hantavirus vaccine enters Phase 3 trials within 12 months — 70% Yes
- Cybersecurity firms to acquire vx-underground’s malware dataset by 2027 — 75% Yes
- Massachusetts passes clergy abuse civil lookback law — 55% Yes
- Cottrell’s cryptocurrency ventures face UK regulatory action within 12 months — 60% Yes
- Congress passes stricter sexual misconduct accountability laws by 2027 — 72% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…